Stable expression of human kinin B-1 receptor in 293 cells: pharmacological and functional characterization

被引:36
作者
Bastian, S
Loillier, B
Paquet, JL
Pruneau, D
机构
[1] Centre de Recherche, Laboratoires Fournier S.A., 21121-Daix
关键词
kinin B-1 receptor; binding; phosphoinositosides cascade; calcium;
D O I
10.1038/sj.bjp.0701380
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 We compared the binding properties of [H-3]-desArg(10)-[Leu(9)]-kallidin, a radiolabelled kinin B-1 receptor antagonist, to membranes from IMR-90 human embryonic fibroblasts and from 293 cells transiently or stably transfected with the human B-1 receptor. 2 The dissociation constant (K-D) of [H-3]-desArg(10)-[Leu(9)]-kallidin and the affinity of several kinin receptor agonists and antagonists were similar between the native and cloned receptor, either transiently or stably expressed in 293 cells. In IMR-90 cells, the rank order of potency was that expected for a kinin B-1 receptor. 3 The receptors transiently or stably expressed in 293 cells were fully functional with respect to their signalling properties. Phosphoinositide hydrolysis was increased in a concentration-dependent manner by the B-1 receptor agonist, desArg(10)-kallidin. Functional coupling to the calcium pathway was also demonstrated for the native and stably expressed human B-1 receptor. 4 In conclusion, the established stable and functional 293 cell clone may provide an important tool for further analysis of the molecular mechanisms involved in binding, activation, and coupling of the kinin B-1 receptor.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 35 条
  • [1] LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS
    BERRIDGE, MJ
    DOWNES, CP
    HANLEY, MR
    [J]. BIOCHEMICAL JOURNAL, 1982, 206 (03) : 587 - 595
  • [2] STUDIES ON THE INDUCTION OF PHARMACOLOGICAL RESPONSES TO DES-ARG9-BRADYKININ INVITRO AND INVIVO
    BOUTHILLIER, J
    DEBLOIS, D
    MARCEAU, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (02) : 257 - 264
  • [3] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [4] Comparative profile of novel potent bradykinin antagonists at human B-1 and B-2 receptors
    Burkard, M
    Zuzack, JS
    Jones, S
    Francis, M
    Walley, ET
    Stewart, JM
    Gera, L
    [J]. IMMUNOPHARMACOLOGY, 1996, 33 (1-3): : 186 - 190
  • [5] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [6] SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION
    CHOMCZYNSKI, P
    SACCHI, N
    [J]. ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) : 156 - 159
  • [7] EFFECT OF GLUCOCORTICOIDS, MONOKINES AND GROWTH-FACTORS ON THE SPONTANEOUSLY DEVELOPING RESPONSES OF THE RABBIT ISOLATED AORTA TO DES-ARG9-BRADYKININ
    DEBLOIS, D
    BOUTHILLIER, J
    MARCEAU, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 93 (04) : 969 - 977
  • [8] DRAPEAU G, 1991, J PHARMACOL EXP THER, V259, P997
  • [9] BRADYKININ AND INFLAMMATORY PAIN
    DRAY, A
    PERKINS, M
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (03) : 99 - 104
  • [10] UP-REGULATION OF [H-3] DES-ARG(10)-KALLIDIN BINDING TO THE BRADYKININ B-1 RECEPTOR BY INTERLEUKIN-1-BETA IN ISOLATED SMOOTH-MUSCLE CELLS - CORRELATION WITH B-1 AGONIST-INDUCED PGI(2) PRODUCTION
    GALIZZI, JP
    BODINIER, MC
    CHAPELAIN, B
    LY, SM
    COUSSY, L
    GIRAUD, S
    NELIAT, G
    JEAN, T
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) : 389 - 394